Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1976 1
1994 1
1995 3
1996 2
1997 3
1998 3
1999 4
2000 5
2001 4
2002 3
2003 4
2004 5
2005 2
2006 3
2007 3
2008 5
2009 8
2010 7
2011 6
2012 4
2013 6
2014 8
2015 8
2016 6
2017 7
2018 10
2019 6
2020 20
2021 20
2022 14
2023 18
2024 14
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Results by year

Filters applied: . Clear all
Page 1
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. Among authors: lichtner m. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Nox2 activation in Covid-19.
Violi F, Oliva A, Cangemi R, Ceccarelli G, Pignatelli P, Carnevale R, Cammisotto V, Lichtner M, Alessandri F, De Angelis M, Miele MC, D'Ettorre G, Ruberto F, Venditti M, Pugliese F, Mastroianni CM. Violi F, et al. Among authors: lichtner m. Redox Biol. 2020 Sep;36:101655. doi: 10.1016/j.redox.2020.101655. Epub 2020 Jul 25. Redox Biol. 2020. PMID: 32738789 Free PMC article.
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Di Biagio A, Sarmati L, Marchetti GC, Bai F, Cingolani A, Quiros Roldan E, Mussini C, Lichtner M, Vergori A, Piconi S, Orofino G, Fusco FM, Bandera A, Nozza S, Castagna A, Antinori A; ICONA Foundation Study Group. d'Arminio Monforte A, et al. Among authors: lichtner m. J Antimicrob Chemother. 2024 Jun 3;79(6):1279-1288. doi: 10.1093/jac/dkae081. J Antimicrob Chemother. 2024. PMID: 38581349
COVID-19 Severity and Androgen Receptor Polymorphism.
Buonacquisto A, Conflitti AC, Pallotti F, Anzuini A, Bianchini S, Caponecchia L, Carraro A, Ciardi MR, Faja F, Fiori C, Gianfrilli D, Lenzi A, Lichtner M, Mastroianni CM, Pasculli P, Rizzo F, Salacone P, Sebastianelli A, Lombardo F, Paoli D. Buonacquisto A, et al. Among authors: lichtner m. Biology (Basel). 2022 Jun 28;11(7):974. doi: 10.3390/biology11070974. Biology (Basel). 2022. PMID: 36101355 Free PMC article.
In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry.
Esposito S, Pagliano P, De Simone G, Guarino A, Pan A, Brambilla P, Mastroianni C, Lichtner M, Brugnaro P, Carretta A, Santantonio T, Brindicci G, Carrega G, Montagnani F, Lapadula G, Spolti A, Luzzati R, Schiaroli E, Scaglione V, Pallotto C, Tacconi D, Quintieri F, Trecarichi E; Italian Society of Infectious, Tropical Diseases. Esposito S, et al. Among authors: lichtner m. Infection. 2024 Aug;52(4):1297-1306. doi: 10.1007/s15010-024-02176-2. Epub 2024 Feb 7. Infection. 2024. PMID: 38324144 Free PMC article.
Neutrophil Cathepsin G and Thrombosis in COVID-19.
Violi F, Bartimoccia S, Cangemi R, Nocella C, D'Amico A, Oliva A, Venditti M, Pugliese F, Mastroianni CM, Ridola L, Lichtner M, Cardinale V, Alvaro D, Cammisotto V, Castellani V, Pignatelli P, Carnevale R. Violi F, et al. Among authors: lichtner m. Circ Res. 2024 Jul 5;135(2):350-352. doi: 10.1161/CIRCRESAHA.124.324649. Epub 2024 May 30. Circ Res. 2024. PMID: 38813720 No abstract available.
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21.
Fabeni L, Armenia D, Abbate I, Gagliardini R, Mazzotta V, Bertoli A, Gennari W, Forbici F, Berno G, Piermatteo L, Borghi V, Pinnetti C, Vergori A, Mondi A, Parruti G, Di Sora F, Iannetta M, Lichtner M, Latini A, Mussini C, Sarmati L, Perno CF, Girardi E, Antinori A, Ceccherini-Silberstein F, Maggi F, Santoro MM; Italian HIV Drug Resistance Group. Fabeni L, et al. Among authors: lichtner m. J Antimicrob Chemother. 2024 Sep 3;79(9):2152-2162. doi: 10.1093/jac/dkae189. J Antimicrob Chemother. 2024. PMID: 39028674 Free PMC article.
Molecular mechanisms of liver fibrosis in HIV/HCV coinfection.
Mastroianni CM, Lichtner M, Mascia C, Zuccalà P, Vullo V. Mastroianni CM, et al. Among authors: lichtner m. Int J Mol Sci. 2014 May 26;15(6):9184-208. doi: 10.3390/ijms15069184. Int J Mol Sci. 2014. PMID: 24865485 Free PMC article. Review.
Enhancing care for people living with HIV: current and future monitoring approaches.
Maggiolo F, Bandera A, Bonora S, Borderi M, Calcagno A, Cattelan A, Cingolani A, Gianotti N, Lichtner M, Lo Caputo S, Madeddu G, Maggi P, Marchetti GC, Maserati R, Nozza S, Rusconi S, Zazzi M, Di Biagio A. Maggiolo F, et al. Among authors: lichtner m. Expert Rev Anti Infect Ther. 2021 Apr;19(4):443-456. doi: 10.1080/14787210.2021.1823217. Epub 2020 Oct 15. Expert Rev Anti Infect Ther. 2021. PMID: 33054479 Free article. Review.
192 results